Recent advances in LDH-based nanosystems for cancer therapy

Cancer has become one of the greatest causes of death around the world. The treatment of cancer still remains a great problem. With recent advances made in the field of nanotechnology, layered double hydroxide (LDH)-based nanosystems have drawn special attention because of their good biocompatibilit...

Full description

Bibliographic Details
Main Authors: Jia Wen, Kui Yang, Jie Huang, Shiguo Sun
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Materials & Design
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127520308340
_version_ 1818564483869573120
author Jia Wen
Kui Yang
Jie Huang
Shiguo Sun
author_facet Jia Wen
Kui Yang
Jie Huang
Shiguo Sun
author_sort Jia Wen
collection DOAJ
description Cancer has become one of the greatest causes of death around the world. The treatment of cancer still remains a great problem. With recent advances made in the field of nanotechnology, layered double hydroxide (LDH)-based nanosystems have drawn special attention because of their good biocompatibility, pH-dependent biodegradability, anion exchange capacity, easy surface modification and high chemical stability, giving rise to great potential for cancer therapy. In the past decade, LDH-based nanosystems have been constructed for various cancer therapies. However, few review articles have described these important and promising achievements to promote the further development of LDH and its nanocomposites. This review aims to provide a comprehensive overview on the recent developments in LDH and its nanocomposites as powerful nanosystems for diverse cancer therapies, which is divided into five parts: chemotherapy, phototherapy, gene therapy, immunotherapy and combination therapy. This review also outlines future perspectives and current challenges in LDH and its nanocomposites for cancer therapy.
first_indexed 2024-12-14T01:29:32Z
format Article
id doaj.art-267275f30caa44aa8bf4b5dc5c813196
institution Directory Open Access Journal
issn 0264-1275
language English
last_indexed 2024-12-14T01:29:32Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Materials & Design
spelling doaj.art-267275f30caa44aa8bf4b5dc5c8131962022-12-21T23:22:04ZengElsevierMaterials & Design0264-12752021-01-01198109298Recent advances in LDH-based nanosystems for cancer therapyJia Wen0Kui Yang1Jie Huang2Shiguo Sun3Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Science, Institute of Life Science and Green Development, Hebei University, Baoding 071002, ChinaLaboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Key Laboratory of Chemical Biology of Hebei Province, College of Chemistry and Environmental Science, Hebei University, Baoding 071002, ChinaKey Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Science, Institute of Life Science and Green Development, Hebei University, Baoding 071002, ChinaCollege of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei 050018, China; Corresponding author.Cancer has become one of the greatest causes of death around the world. The treatment of cancer still remains a great problem. With recent advances made in the field of nanotechnology, layered double hydroxide (LDH)-based nanosystems have drawn special attention because of their good biocompatibility, pH-dependent biodegradability, anion exchange capacity, easy surface modification and high chemical stability, giving rise to great potential for cancer therapy. In the past decade, LDH-based nanosystems have been constructed for various cancer therapies. However, few review articles have described these important and promising achievements to promote the further development of LDH and its nanocomposites. This review aims to provide a comprehensive overview on the recent developments in LDH and its nanocomposites as powerful nanosystems for diverse cancer therapies, which is divided into five parts: chemotherapy, phototherapy, gene therapy, immunotherapy and combination therapy. This review also outlines future perspectives and current challenges in LDH and its nanocomposites for cancer therapy.http://www.sciencedirect.com/science/article/pii/S0264127520308340Layered double hydroxideChemotherapyPhototherapyGene therapyImmunotherapyCombination therapy
spellingShingle Jia Wen
Kui Yang
Jie Huang
Shiguo Sun
Recent advances in LDH-based nanosystems for cancer therapy
Materials & Design
Layered double hydroxide
Chemotherapy
Phototherapy
Gene therapy
Immunotherapy
Combination therapy
title Recent advances in LDH-based nanosystems for cancer therapy
title_full Recent advances in LDH-based nanosystems for cancer therapy
title_fullStr Recent advances in LDH-based nanosystems for cancer therapy
title_full_unstemmed Recent advances in LDH-based nanosystems for cancer therapy
title_short Recent advances in LDH-based nanosystems for cancer therapy
title_sort recent advances in ldh based nanosystems for cancer therapy
topic Layered double hydroxide
Chemotherapy
Phototherapy
Gene therapy
Immunotherapy
Combination therapy
url http://www.sciencedirect.com/science/article/pii/S0264127520308340
work_keys_str_mv AT jiawen recentadvancesinldhbasednanosystemsforcancertherapy
AT kuiyang recentadvancesinldhbasednanosystemsforcancertherapy
AT jiehuang recentadvancesinldhbasednanosystemsforcancertherapy
AT shiguosun recentadvancesinldhbasednanosystemsforcancertherapy